• 54,773+ CME Conference Registrations Sold
  • 164,320+ Medical Conferences
  • 297 Specialties
  • 11,712 Organizers
  • 159,479 Speakers
  • 159 Countries
  • 4,843 Cities
Duration: CME/CE Points: Faculty:
15 Minutes
CME : 0.25

Advances in Anti-Cytokine Therapy: New Pathways (IL 12/23, IL 17, IL 23) is organized by Cleveland Clinic Foundation Center for Continuing Education.

Release Date: May 09, 2018
Expiration Date: May 09, 2020 

The target audience for this medical event is rheumatologists, dermatologists, gastroenterologists, allergists, clinical immunologists, and specializes in infectious disease, integrative medicine, primary care and other healthcare professionals caring for patients with immunologic diseases. This CME Conference has been approved for a maximum of 0.25 AMA PRA Category 1 Credit.

Course Description:
Basic and Clinical Immunology series provides clinicians with a review of basic and clinical immunology. It is comprised of A-B-C teaching with an emphasis on biologic principles and implications and focuses on three areas- basic overview of immunology, a review of current advances, and biologic therapies for IMIDS.

This webcast will review the current advances in anti-cytokine therapy, as well as the treatment gaps.

Learning Objectives:
• Highlight current advances in the understanding of psoriatic arthritis and rational for anti-cytokine therapy
• Explain the mechanism of action, efficacy and potential evidence based role of newer and emerging therapies
• Identify timely and aggressive treatment strategies and gaps for patients with psoriatic disease

Additional details will be posted as soon as they are available.

Target Audience



Activity Fee : Fee Details will be updated soon



Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.